Weight care · Texas
GLP-1 shots vs pills: Wegovy pill, Foundayo, Wegovy pen and Zepbound
You can now take a GLP-1 as a weekly shot or a daily pill. The medicine class is the same idea — it acts on appetite and blood sugar — but the products, schedules and cash prices differ. Level prescribes FDA-approved options only. We do not offer compounded semaglutide or tirzepatide.
The daily pills
Wegovy® pill (oral semaglutide) was FDA-approved for chronic weight management on December 22, 2025. Through NovoCare, published self-pay prices (checked November 2026) are $149/mo at 1.5 mg, $199 at 4 mg, and $299 at 9 mg or 25 mg. It is taken on an empty stomach with a sip of water, then you wait 30 minutes before food, drink or other oral medicines. It also has a cardiovascular-risk indication on the brand label.
Foundayo™ (orforglipron) was FDA-approved on April 1, 2026. It is a daily oral GLP-1 agonist. Through LillyDirect, published self-pay prices (checked November 2026) are $149 (0.8 and 2.5 mg), $199 for 5.5 mg (a promotional price through December 31, 2026), and $299 at higher doses (9, 14.5 and 17.2 mg). It can be taken any time of day, with or without food, and has no water-volume limit like the Wegovy pill.
The weekly shots
Wegovy® injection (semaglutide) and Zepbound® (tirzepatide) are once-weekly pens (Zepbound also has a vial). In large trials, average weight loss was about 15% with Wegovy 2.4 mg (STEP 1) and about 21% with Zepbound 15 mg (SURMOUNT-1), versus a few percent with placebo. Individual results vary, and weight often returns if the medicine is stopped.
Manufacturer self-pay (checked November 2026): Zepbound vials and pens from $299/mo at 2.5 mg through LillyDirect, with higher doses priced higher; Wegovy pens $199 for each of the first two fills for new patients through December 31, 2026, then $349/mo through NovoCare. See the injections page for the current published breakdown.
What we charge
Level’s care fee is $79/mo for doctor visits, dose check-ins and messaging. Level is cash-pay and does not bill or accept traditional health insurance. You pay the manufacturer’s published self-pay price for the medicine, with no markup from us. If you want to try your own insurer, your doctor can send the prescription to your retail pharmacy instead — that billing is not through Level.
Muscle while you lose fat
GLP-1 medicines reduce fat, but some of the weight lost is lean soft tissue. That is not unique to one brand. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adults on tirzepatide who added three weekly resistance-training sessions lost less lean soft tissue (3.57 kg vs 4.67 kg) than those who did their usual activities, while fat loss was similar, and strength went up instead of down (Green et al.).
Every Level GLP-1 plan includes a muscle-protection plan: a protein target, guidance to lift or do other resistance training about 2–3 days a week, and follow-up from your care team. We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee you will keep every pound of muscle. Retatrutide is sometimes discussed as “muscle-sparing,” but it is not FDA-approved (Lilly has said it plans to file in the first quarter of 2027), and a DXA substudy of retatrutide did not show a uniquely muscle-sparing pattern. You can join a notify list; we will not sell it before approval.
Safety, in brief
Do not use a GLP-1 if you or a family member have had medullary thyroid carcinoma (MTC) or MEN 2. Tell your doctor about pancreatitis, gallbladder disease, pregnancy or plans to conceive, type 1 diabetes, and whether you use insulin or a sulfonylurea. Common effects include nausea, vomiting, diarrhea or constipation, which often ease as the dose is increased slowly. Read the Medication Guide that comes with your prescription.
Is a GLP-1 pill as effective as a shot?
They are different products with their own trial results, doses and instructions. Your doctor will match the option to your health, schedule and budget. We don’t claim one is universally “better.”
Do you offer compounded semaglutide or tirzepatide?
No. We prescribe FDA-approved Wegovy, Zepbound and Foundayo at the manufacturer’s published self-pay price, plus a $79/mo care fee.
Sources
- Wegovy Medication Guide (Novo Nordisk)
- NovoCare: Wegovy self-pay prices (pill and pen)
- LillyDirect: Zepbound self-pay prices
- LillyDirect: Foundayo self-pay prices
- Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021
- Jastreboff et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- Green DJ, Haynes A, Underwood DR, et al. Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial. Nat Med. Published 9 Nov 2026.
- Lilly: Retatrutide clinical development (read Nov 2026)
Prices checked Nov 2026. This page is general information, not medical advice.
Last updated .